Treatment of Parkinson's disease in a patient with acute intermittent porphyria.
Gorchein
A
A
D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001545:Benserazide / Q000627:therapeutic use; D002746:Chlorpromazine / Q000009:adverse effects; D018492:Dopamine Antagonists / Q000009:adverse effects; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D017118:Porphyria, Acute Intermittent / Q000150:complications*; D014282:Trihexyphenidyl / Q000627:therapeutic use*
D000978:Antiparkinson Agents; D018492:Dopamine Antagonists; D007980:Levodopa; D014282:Trihexyphenidyl; D001545:Benserazide; D002746:Chlorpromazine